Search

Your search keyword '"Tumors -- Drug therapy -- Genetic aspects"' showing total 1 results
Start Over Descriptor "Tumors -- Drug therapy -- Genetic aspects" Publisher plus media

Refine your results

1 results on '"Tumors -- Drug therapy -- Genetic aspects"'

1. Senhwa Announces Multiple IND Application Submissions to US FDA and Health Canada for the Treatment of Solid Tumors with BRCA2 or PALB2 Mutations

Subjects
United States. Food and Drug Administration, Cancer treatment, Talazoparib, Cancer research -- Genetic aspects, Tumors -- Drug therapy -- Genetic aspects, General interest, News, opinion and commentary
Abstract

TAIPEI: Senhwa Biosciences, Inc. has issued the following news release: Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results